Mankind Pharma rallies 32% on day 1

May 10, 2023

At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.

More To Explore

Nifty faces stiff resistance near 25,100; sector rotation is key

Markets remain cautious below the 25100 resistance, vulnerable to corrections and volatility. Sector rotation, profit protection, and modest leverage are key amid shifting momentum across

May 24, 2025

Eternal may see outflows worth $840 million following FTSE, MSCI’s weight cuts

Eternal, formerly Zomato, may see passive outflows of $840 million as FTSE and MSCI reduce its index weightage due to a Foreign Ownership Limit cut,

May 24, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003